Marker Therapeutics, Inc. (MRKR) › Total LiabilitiesMarker Therapeutics, Inc. (MRKR) — Total LiabilitiesAnnual figures by period end, from SEC filings.2016-12-31: $1.74M2017-12-31: $1.52M2018-12-31: $2.80M2019-12-31: $2.27M2020-12-31: $18.27M2021-12-31: $24.15M2022-12-31: $14.82M2023-12-31: $3.07M2024-12-31: $3.46M2025-12-31: $2.27M$2.27M2016-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$2.27M-34.4%2026-03-18Balance as of period end2024-12-31$3.46M+12.7%2026-03-18Balance as of period end2023-12-31$3.07M-79.3%2025-03-31Balance as of period end2022-12-31$14.82M-38.6%2024-03-26Balance as of period end2021-12-31$24.15M+32.2%2023-03-22Balance as of period end2020-12-31$18.27M+703.8%2022-03-17Balance as of period end2019-12-31$2.27M-18.9%2021-03-09Balance as of period end2018-12-31$2.80M+84.2%2020-03-12Balance as of period end2017-12-31$1.52M-12.3%2019-03-15Balance as of period end2016-12-31$1.74M—2018-03-23Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)